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Introduction: While fever is the main complaint among pediatric emergency services
and high antibiotic prescription are observed, only a few studies have been published
addressing this subject. Therefore this systematic review aims to summarize antibiotic
prescriptions in febrile children at the ED and assess its determinants.
Methods: We extracted studies published from 2000 to 2017 on antibiotic use in febrile
children at the ED from different databases. Author, year, and country of publishing, study
design, inclusion criteria, primary outcome, age, and number of children included in the
study was extracted. To compare the risk-of-bias all articles were assessed using the
MINORS criteria. For the final quality assessment we additionally used the sample size
and the primary outcome.
Results: We included 26 studies reporting on antibiotic prescription and 28 intervention
studies on the effect on antibiotic prescription. In all 54 studies antibiotic prescriptions
in the ED varied from 15 to 90.5%, pending on study populations and diagnosis.
Respiratory tract infections were mostly studied. Pediatric emergency physicians
prescribed significantly less antibiotics then general emergency physicians. Most
frequent reported interventions to reduce antibiotics are delayed antibiotic prescription
in acute otitis media, viral testing and guidelines.
Conclusion: Evidence on antibiotic prescriptions in children with fever presenting to
the ED remains inconclusive. Delayed antibiotic prescription in acute otitis media and
guidelines for fever and respiratory infections can effectively reduce antibiotic prescription
in the ED. The large heterogeneity of type of studies and included populations limits strict
conclusions, such a gap in knowledge on the determining factors that influence antibiotic
prescription in febrile children presenting to the ED remains.
Keywords: pediatric emergency care, fever, children, antibiotic prescription, management
van de Voort et al. Antibiotic Use in Febrile Children in the ED
INTRODUCTION
Fever is the main complaint among pediatric emergency services
(1). In only 15% (IQR 8·0–23·2%) a serious bacterial infection
(SBI) is diagnosed with pneumonia and urinary tract infection
(UTI) being the most prevalent (2, 3).
In contrast to the above, high antibiotic prescriptions
are observed in febrile children (4, 5). Guidelines, or new
diagnostic approaches have shown to effectively reduce antibiotic
prescriptions in primary care (6–9). This is important because
unnecessary antibiotic use increases antibiotic resistance (10, 11).
In contrast to hospital based studies or primary care settings
(11–15), few studies have been published in emergency
department (ED) settings nor do we have valid estimates of
potential benefits of antibiotic reducing interventions. Therefore
our primary study aim is to assess antibiotic prescriptions
for febrile children visiting the emergency department and
their determinants. Secondary, we aim to investigate potential
interventions that have been proven to be effective in the ED.
METHODS
Study Characteristics
All descriptive and interventional studies published in 2000–2017
reporting on antibiotic use in children (age under 18) with fever
in the emergency department were eligible for this review.
Search Strategy
We searched Embase, Medline (OvidSP), Web-of-science,
Scopus, Cinahl, Cochrane, PubMed publisher, and Google
scholar for the (analogs of) keywords: fever, antibiotics,
emergency department, children and antibiotic prescription.
Initially search was performed in 2015 and updated in October
2017 (Supplementary Material 1). References were checked for
additional articles to be included.
Inclusion
A screening by title/abstract resulted in potential eligible articles
that underwent full text review. Two authors reviewed all
articles; any discrepancies were solved by oral agreement between
authors.
– Setting: Emergency department; if mixed settings, at least
30% (50 patients minimum) of the population needed to be
admitted to the ED.
Abbreviations: AB, antibiotic(s); AOM, acute otitis media; ARS, acute respiratory
symptoms; ARTI, acute respiratory tract infection; BC, blood culture; CAP,
community acquired pneumonia; CC, case control study; CI, confidence interval;
CP, cohort study, prospective; CR, cohort study, retrospective; CS, cross sectional
study; CSF, cerebrospinal fluid; d, days; ED, emergency department; EL, extreme
leukocytosis; FWS, fever without source; GED, general emergency department;
GEMP, general emergency medicine physician; ILI, influenza-like illness; ML,
moderate leukocytosis; mo, months; NR, not reported; NS, not specified; PED,
pediatric emergency department; PEMP, pediatric emergency medicine physician;
qRCT, quasi-randomized controlled trial; RCT, randomized controlled trial; reg,
registration; RIDT, rapid influenza diagnostic tests; RST, rapid streptococcal test;
RVT, rapid viral testing; SBI, serious bacterial infection; SD, standard deviation; T,
temperature; URTI, upper respiratory tract infection; UTI, urinary tract infection;
y, years.
– Design: observational studies and randomized controlled trials
with a minimum of 50 participants.
– Outcome: the studies had to report the number or percentage
of antibiotics prescribed.
– Population: participants under the age of 18; if mixed ages, at
least 20% of the population needed to be <18 years (with a
minimum of 50) or age specific antibiotic prescriptions had to
be presented. Studies on children with specific comorbidities
only were excluded.
– Fever: at least 30% of all included children needed to have fever
or the reason of visit was (reported) fever.
Quality Assessment of Included Articles
To compare the risk-of-bias of all these different study designs
all articles were assessed using the MINORS criteria (16). Zero
points were given for the item if not reported, one point if
reported but insufficient and two points if reported and sufficient.
As loss to follow-up was not applicable, due to emergency
setting, we have let this particular item out of consideration;
the maximum score for studies is 14 or 22 for respectively
non-comparative and comparative studies. A maximum score
on the MINORS criteria was needed to receive the status of a
low risk of bias study (A) (17). For the final quality assessment
we additionally used the sample size and the primary outcome.
A high quality study was defined by status low risk of bias
(A) on the MINORS, antibiotic prescription being the primary
outcome and a sample size of at least 500 children. Two
reviewers (EV and RO) have independently assessed all included
studies. Supplementary Material 2 contains the complete quality
assessment.
Data Extraction and Analysis
Extracted data included: Author, year, and country of publishing,
study design, inclusion criteria, primary outcome, median
(or mean when median not available) age, number of
included children. Aiming to invest determinants of antibiotic
prescription, we additionally extracted (if available): diagnosis,
type of antibiotics, type of physicians, and type of intervention.
Due to heterogeneity in participants, outcome measures,
interventions and study designs, no statistical pooling but a
qualitative analysis was performed (18). Results are presented
for the 5 main diagnosis, i.e., fever, AOM, pneumonia, other
respiratory tract infections (RTI other) andUTI, with aminimum
of 50 cases per diagnostic group required.
RESULTS
Literature Search
We obtained 837 articles by literature search. Screening the full
text articles excluded 97 out of 151, which leaves 52 articles
for data extraction. Two additional studies were included by
reference check of included studies (Figure 1).
Characteristics of the Included Studies
The study characteristics are presented in Table 1 for the
included 54 studies. Most studies come from the US (n = 32,
59%), 16 others came from Europe, and 6 others from Canada
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FIGURE 1 | Flowchart of the study selection and exclusion.
(n= 3) (33, 36, 49), Australia (n= 2) (3), and Israel (n= 1) (26).
The size of the studied population varied between 72 and 266.000
participants (median = 391). Most studies included children up
to 36 months (n = 14, 25%) or all ages < 18 year (n = 18, 32%).
Antibiotic prescription was the primary outcome in 33 studies
(59%). Quality and feasibility assessment of the included studies
(Supplementary Material 2).
Sixteen studies (29%) were considered as high quality and
17 (30%) were considered low quality. In general, observational
studies did not describe sufficiently how sample size was
approximated. Almost all high quality studies, except one (3),
used antibiotic prescriptions as a primary outcome.
Antibiotic Prescriptions in Febrile Children
and Specific Conditions
Table 2 presents the antibiotic prescriptions among the five
diagnostic groups we distinguished. Sixteen out of 26 descriptive
studies focused on febrile children in general, one paper
specifically addressed acute otitis media (AOM) (30), two
pneumonia (45, 63), four other respiratory infections (RTI
other)(19, 23, 43, 57), and one urinary tract infections (UTI)(32).
One paper on febrile children also provide separate numbers for
pneumonia and UTI (3) and one for AOM (61). Two additional
papers focused on respiratory infections and provided separate
numbers for pneumonia, AOM and RTI other (44, 56).
Fever
Sixteen out of 26 studies focused on febrile children in
general, seven of them selected children based on fever without
source; five included febrile children based on additional testing
(Table 2). In studies of general febrile populations only, antibiotic
prescriptions ranged from 15 to 71% (3, 31, 35, 36, 39, 42, 50,
61, 71). The lowest prescriptions (15%) came from a study on
parenteral empirical antibiotics only (50). Study quality did not
influence antibiotic prescription rate.
Three high quality, six moderate quality and two low quality
studies reported on SBI rate, which ranged from 7 to 41%
(Figure 2) (3, 26, 35–38, 42, 44, 50, 60, 71). As the SBI rate
in Khine et al. (42) is similar to antibiotic prescriptions, one
may question how SBI is defined. Massin et al. (50) reports
on parenteral antibiotics only and may not represent antibiotic
prescription in total. Focusing on the remaining eight studies,
we observe a trend toward higher antibiotic prescriptions with
higher rates of SBI, although not significant.
In the studies on fever in general, we observed a higher
prescriptions in children under the age of one (45 to 71%;
weighted mean 58%), compared to older ones (prescriptions of
17 to 44%; weighted mean 28%), independent of study quality
(Figure 3) (3, 28, 31, 35–37, 39, 42, 50, 71).
None of the studies on febrile children in general compared
antibiotic prescriptions between countries. In the eleven studies
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TABLE 1 | Characteristics of descriptive studies about antibiotic prescription.
Reference, Country Study
design
Age group/
inclusion
Median (IQR) or
Mean age ± SD
Inclusion criteria N children
included
Quality
Ahmed et al. (19), US CSp 0–18 years NR URTI 321 Low
Angoulvant et al. (20),
France
CR <18 years 17 months (7–40) ARTI 53.055 High
Aronson et al. (21), US CSr 29–56 days 46 days (37–53) Fever 1626 High
45 days (37–53)
Ayanruoh et al. (22), US CSr 3–18 years NR Clinical diagnosis of pharyngitis 8280 Low
Benin et al. (23), US CSr 3–18 years 8.7 years (6–13) Diagnosis pharyngitis 391 Moderate
Benito-Fernández et al.
(24), Spain
CP 0–36 months 6.86 months ± 6.3◦ Fever without source 206 Low
6.55 months ± 6.8◦
Blaschke et al. (25) US⋄ CSr All ages 53% <18 years Influenza 58 Low
Brauner et al. (26),
Israel
CCr 3–36 months NR Fever and complete blood count 292 Moderate
Bonner et al. (27), US RCT 2 months−21
years
NR Influenza 202 Moderate
Bustinduy et al. (28),
UK
CP <16 years 2 years (1–4 years) Fever or reported fever 1097 Moderate
Chao et al. (29), US RCT 2–12 years 5.01 years (3.67–6.68) AOM 206 Moderate
3.73 years (2.82–5.75)
Craig et al. (3), Australia CP <6 years ± 60% <24 months Fever 15.781 High
Coco et al. (30), US CSr <12 years ± 2 years* AOM 8325 High
Colvin et al. (31), US CP 2–36 months 8.0 months Fever without source U 75 Low
Copp et al. (32), US CSr <18 years ±6 years* UTI 1828 (36% in ED) Low
Doan et al. (33),
Canada
RCT 3–36 months 15 months (3–36) Acue respiratory symptoms 199 Moderate
14 months (4–34)
Fischer et al. (34), US CP 2–18 years 68% 2–6 years AOM 144 Low
Galetto Lacour et al.
(35), Switzerland
CP 7 days −36
months
11 months* Fever without source U 124 Moderate
Galetto-Lacour et al.
(35), Switzerland
CP 7 days −36
months
7.2 months (0.4–31.1) Fever without source U 99 Low
9.7 months (0.7–34)
Goldman et al. (36),
Canada
CP <3 months 48.7 days ± 23.6◦ Fever 257 Low
Houten et al. (37),
Netherlands
CP 2–60 months 21 months ± 16◦ Fever and LRTI symptoms or without
source
577 Moderate
Irwin et al. (38), UK CP <16 years 2.4 years (0.9–5.7) Fever and blood tests 1101 High
Isaacman et al. (39), US CR 3–36 months 18 months ± 9.8◦ Fever without source in a GEDU 79 Low
16.3 months ±8.8◦ Fever without source in a PEDU 498
Iyer et al. (40), US RCT 2–24 months ±75% 6–24 months Fever 700 Moderate
Jain et al. (41), US CP <18 years NR Fever 19075 High
Khine et al. (42), US CR 3–36 months 15.2 months ±8.7◦ Reported fever in GED 237 Moderate
3–36 months 16.6 months ±9.1◦ Reported fever in PED 224
Kilic et al. (43) Turkey CSr 3–140 months 41.2 months ±31◦ Asthma, croup, Bronchiolitis 2544 Low
Kornblith et al. (44), US CSr 0–18 years ± 56% 1–5 years ARTI 6461 High
Kronman et al. (45), US CSr 1–18 years 50–60% 1–5 years CAP 266.000 High
Lacroix et al. (46),
France
RCT 7 days−36
months
3.4 months (1.5–10.4) Fever without source 271 High
4.8 months (1.7–10.4)
(Continued)
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TABLE 1 | Continued
Reference, Country Study
design
Age group/
inclusion
Median (IQR) or
Mean age ± SD
Inclusion criteria N children
included
Quality
Linder et al. (47), US CSr 3–17 years 45% 6–11 years Sore throat 6955 High
Li-Kim-Moy et al. (48),
Australia
CR 0 ≤ 18 years 3.1 years (1.1–7.4) Lab proven influenza 301 Moderate
Manzano et al. (49),
Canada
RCT 1–36 months 12 ± 8 months◦ Fever 384 High
12 ± 8 months◦
Massin et al. (50)
Belgium
CP 1–36 months 13.8 months ±9.7◦ Fever without source U 376 Moderate
McCaig et al. (51), US CSr 3 months−2 years NR Fever and BC (discharged) 5.4% of all ED
visits
Low
McCormick et al. (52),
US
RCT 6–72 months ±60% <1 years AOM 209 Moderate
Murray et al. (53), US CP <56 days 36 days ± 13.8 Fever 520 Low
Nelson et al. (54), US* CP 3 months−18
years
2.8 years (4.4) Pneumonia 3220 High
Nibhanipudi et al. (55),
US*
CP 2–17 years 5.72 years ± 0.38◦ (m) AOM 100 Low
7.41 years ± 0.75◦ (f)
Ochoa et al. (56), Spain CSr 0–18 years ±3 years (1
months−18 years)
ARTI 6249 High
Ong et al. (57), US CP All ages (20%
child)
33 years URTI 272 Moderate
Özkaya et al. (58),
Turkey
CSp 3–14 years 5.7 years ± 3.4◦ Influenza like illness 97 Low
4.25 years ± 2.02
Ouldali et al. (59),
France
qRCT <18 years 1.6 years (0.7–3.6) ARTI 196.062 High
1.7 years (0.7–3.7)
Planas et al. (60), Spain CP <3 months 35 days ± 31◦ Fever without source and BC
(admitted) U
381 Moderate
Ploin et al. (61), France CP <36 months NR Fever during influenza season 538 Moderate
Poehling et al. (62), US RCT <5 years NR Fever or ARS during influenza season 305 Moderate
Shah et al. (63), US CSr 1–18 years ± 63% 1–4 years Fever and cough or respiratory
distress
3466 Moderate
Sharma et al. (64), US CSr 2–24 months 9 months ◦ Fever and positive influenza test 72 Low
Spiro et al. (65), US RCT 6–35 months 17.3 months◦ Fever or ARS 681 High
17.2 months◦
Spiro et al. (66), US RCT 6 months−12
years
3.2 years AOM 283 High
3.6 years
Trautner et al. (67), US CSp <18 years 17 months (11–25
months)
Hyperpyrexia 103 Moderate
de Vos-Kerkhof et al.
(68), Netherlands
RCT 1 months−16
years
1.7 years (0.8–3.9) Fever 439 Moderate
2.0 years (1.0–4.2)
Waddle and Jhaveri,
(69), US
CSr 3–36 months 17 months ± 11◦ FWS and BC 423 Low
15 months ± 10◦
Wheeler et al. (70), US CP ≤18 years 3 years (1 months−20
years)
Viral infections 144 Moderate
CC, case control; CP, prospective cohort; CR, retrospective cohort; CS, cross-sectional; r, retrospective; p, prospective.
*Estimated/calculated from numbers in article. ◦Mean age is given, median age was not reported. U Fever without source: as defined in corresponding study.
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TABLE 2 | Antibiotic prescription per diagnosis.
Reference, Country Age group/
inclusion
Median (IQR) or
Mean age ± SD
Inclusion criteria N children
included
N antibiotics,
% of study
populationł
FEVER IN GENERAL
Bustinduy et al. (28),
UK
<16 years 2 years (1–4 years) Fever or reported fever 1097 44%
Colvin et al. (31), US 2–36 months 8.0 months Fever without source U 75 45%
Craig et al. (3), Australia <6 years ± 60% <24 months Fever 15.781 27%
Galetto Lacour et al.
(35), Switzerland
7 days−36
months
11 months* Fever without source U 124 62.1%
Galetto-Lacour et al.
(35), Switzerland
7 days−36
months
7.2 months (0.4–31.1)
9.7 months (0.7–34)
Fever without source U 99 71%
Goldman et al. (36),
Canada
<3 months 48.7 days ± 23.6◦ Fever 257 55%
Houten et al. (60),
Netherlands
2–60 months 21 months ± 16◦ Fever and LRTI symptoms or
without source
577 39%
Isaacman et al. (39), US 3–36 months 18 months ± 9.8◦ Fever without source in a GEDU 79 39.2%
16.3 months ±8.8◦ Fever without source in a PEDU 498 16.7%
Khine et al. (42), US 3–36 months 15.2 months ±8.7◦ Reported fever in GED 237 41%
3–36 months 16.6 months ±9.1◦ Reported fever in PED 224 27%
Massin et al. (50),
Belgium
1–36 months 13.8 months ± 9.7◦ Fever without source U 376 15%
Ploin et al. (61), France <36 months NR Fever during influenza season 538 34.8%
FEVER AND SELECTION ON ADDITIONAL TESTING OR CHARACTERISTICS
Irwin et al. (38), UK <16 years 2.4 years (0.9–5.7) Fever and blood tests 1101 855, 78%
Trautner et al. (67), US <18 years 17 months (11–25
months)
Hyperpyrexia 103 46, 61.3%
Brauner et al. (26),
Israel
3–36 months NR Fever and complete blood count 292 148, 50.7%
Planas et al. (60), Spain <3 months 35 days ± 31◦ Fever without source and BC
(admitted) U
381 281, 73.8*%
AOM
Coco et al. (30), US <12 years ± 2 years* AOM 8325 82.6%
Kornblith et al. (44), US 0–18 years ± 56% 1–5 years AOM 647 88%
Ochoa et al. (56), Spain 0–18 years ±3 years (1
months−18 years)
AOM 821 93%
Ploin et al. (61), France <36 months NR Fever during influenza season 18 89%
PNEUMONIA
Craig et al. (3) Australia <6 years ± 60% <24 months Pneumonia 533 69%
Kornblith et al. (44), US 0–18 years ± 56% 1–5 years Pneumonia 657 86%
Kronman et al. (45), US 1–18 years 50–60% 1–5 years CAP 266.000 86.1%
Ochoa et al. (56), Spain 0–18 years ±3 years (1
months−18 years)
Pneumonia 288 93%
Shah et al. (63), US 1–18 years ± 63% 1–4 years Pneumonia 347 82%
RTI OTHER
Ahmed et al. (19), US 0–18 years NR URTI 321 43%
Benin et al. (23), US 3–18 years 8.7 years (6–13) Diagnosis pharyngitis 391 23%
Kilic et al. (43), Turkey 3–140 months 41.2 months ±31◦ Asthma, croup, Bronchiolitis 2544 16.6%
Kornblith et al. (44), US 0–18 years ± 56% 1–5 years URTI 5157 36%
Ochoa et al. (56), Spain 0–18 years ±3 years (1
months−18 years)
URTI 5140 51%
Ong et al. (57), US All ages (20%
child)
33 years URTI 272 83, 31%
UTI
Copp et al. (32), US <18 years ±6 years* UTI 1828 70%
Craig et al. (3), Australia <6 years ± 60% <24 months Fever 543 66%
*Estimated/calculated from numbers in article.
◦Mean age is given, median age was not reported.
UFever without source: as defined in corresponding study.
łAntibiotic prescription is given for reported age group, except for Ong et al (57) antibiotic use for all ages is given.
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FIGURE 2 | Serious bacterial infection rate and antibiotic prescriptions per study. High/Moderate quality, High/Moderate quality, outlier, Low quality, Low
quality, outlie.
FIGURE 3 | Antibiotic prescriptions arranged on age in children with fever. Studies are arranged by age, i.e., left represents younger children to right (older ages). Light
bars represent studies with a low quality.
(3, 28, 31, 35–37, 39, 42, 50, 61, 71) on children with fever in
general (without additional testing), the highest prescriptions
were reported in a Swiss study (71%) (35) and the lowest in
a study originating from the US (17%) (39). The three studies
originating from the US reported antibiotic prescription between
39–45% (31, 39, 42); for the two Swiss studies this varied
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FIGURE 4 | Type of antibiotic as percentage of total antibiotics prescribed per study. *As defined in article. Ahmed et al. (19): not specified; Copp et al. (32):
nitrofurantoin and others are not specified antibiotics. Coco et al. (30): not specified. Ochoa et al. (56): trimethoprim/sulfamethoxazole, clindamycin, fosfomycin,
rifampin, trimethoprim, topical use and others are not specified. Ong et al. (57): trimethoprim/sulfamethoxazole; Shah et al. (63): not specified. ∧Calculated from article
as percentage of total antibiotics, in article given as percentage of cases.
from 62 to 71%, although originating from the same hospital
(35, 71).
Antibiotic Prescription for Specific Diagnoses
Four studies provided data for antibiotic prescription in AOM,
ranging from 88–93%. We could not determine influences of age
on prescriptions. Five studies reported on antibiotic prescription
in pneumonia, ranging from 69 to 93%. The study with the lowest
prescription (3) included children <6 years only compared to
the other four (including children in the range of 1-18 years).
Antibiotic prescription in RTI other (6 studies) varied on a
broader range from 17 to 51%, but could not be related to age.
Only two studies provided information on antibiotic prescription
in UTI, ranging from 66 to 70%.
Type of Antibiotic Prescription
Nine out of 26 (35%) studies [two high quality (30, 56)]
reported on antibiotic type (Figure 4). Six studies addressed
respiratory tract infections (19, 30, 43, 56, 57, 63) and five
were conducted in the US (19, 30, 32, 57, 63). We did not
observe a predominance for one antibiotic type for a specific
diagnosis or country; amoxicillin was always reported. Studies
describing cephalosporin use (n = 7) included both second or
third generations.
Prescribing Physician
Five (39, 42, 47, 63, 72) out of seven studies [three high
quality studies (44, 47, 66)], reported significant lower antibiotic
prescriptions by pediatric emergency physicians compared to
general emergency physicians (Table 3). Two addressed young
children with fever without source (39, 42), and five addressed
older children with respiratory tract infections (19, 44, 47, 63, 65).
The Effect of Interventions on Antibiotic
Prescription
Nine out of 27 studies on interventions for antibiotic prescription
(32%) reported about rapid viral testing (22, 24, 25, 27, 33, 40, 58,
62, 64), four about delayed antibiotic prescription in acute otitis
media (29, 34, 52, 66), six about guideline/management strategies
(20, 21, 41, 53, 59, 68), four about laboratory tests (22, 46, 47, 49)
and five using other interventions (Table 4). In fourteen studies
(50%) a significant reduction in antibiotic use was found.
Interventions for AOM
Interventions with a significant effect on antibiotic reduction
were guidelines and the wait-and-see prescription in acute otitis
media (AOM). For this latter a significant reduction was found
in four articles (three of them with moderate to high quality)
(29, 34, 52, 66).
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TABLE 3 | Difference in antibiotic prescription between general physicians and
pediatric physicians.
Reference, Country N Antibiotics
given by
GEMP/N seen
by GEMP %
antibiotics
N antibiotics
given by
PEMP/N seen
by PEMP %
antibiotics
Inclusion
criteria
Isaacman et al. (39), US 37/79, 39% 83/498, 17% FWS
Khine et al. (42), US 97/237, 41% 61/224, 27% FWS
Ahmed et al. (19), US NR/238, 32% NR/345, 17% URTI
Kornblith et al. (44), US NR, 46% NR, 42% ARTI
Shah et al. (63), US 2946, 50% 520, 35% Febrile RTI
Linder et al. (47), US NR, 60% NR, 47% Sore throat
Spiro et al. (65), US* NR, 30% NR, 26% Fever/ARS
*No significant statistical difference was found.
High quality study.
Moderate quality study.
Low quality study.
Viral Testing Intervention
Most studies on interventions for reduction of antibiotic
prescription addressed rapid viral testing for influenza (RVT, n
= 9). Fewer antibiotics were prescribed when the RVT is positive
(24, 25, 27, 64), although not confirmed by studies on the impact
of RVT use vs. not using RVT in the ED (27, 40, 58, 62). Only one
low quality study reported a significant difference for this topic
(58). The use of point-of-care testing above testing on indication
had only significant benefit in children with proven influenza
(33, 48). One study reported reduced length of stay, but no effect
on antibiotic prescription (48).
Other Interventions
Three high quality studies showed a significant reduction in
antibiotic prescription by a guideline for lower respiratory
infections or infants with fever (20, 21, 41). Among two articles
on streptococcal A testing, the article with the highest quality
didn’t find a significant reduction (22, 47). Introduction of
a clinical pathway for young febrile infants showed reduced
time to first antibiotic dose, but did not evaluate the effect on
antibiotic prescription itself (53). The use of chest radiographs
in particular reduces antibiotics in children with low clinical
suspicion of pneumonia (54). For all other interventions no
significant reduction was found on antibiotic prescription (46, 49,
65, 69, 70).
DISCUSSION
Interpretation of Main Findings
We observed a highly variable reported antibiotic prescriptions
in children presenting to a general or pediatric ED in the five
major groups of diagnosis. Studies on a specific diagnosis, such as
AOM, pneumonia, or UTI report higher antibiotic prescriptions.
However, studies are too heterogeneous to study true effects of
determinants. Strong evidence was found for watchful waiting in
AOM and implementation of guidelines for fever or respiratory
infections to reduce antibiotic use in the ED. Intervention studies
report mostly on rapid viral testing for influenzae (RVT) to
reduce antibiotic prescription, but its effect is controversial.
It is important to note that the high variability in antibiotic
prescription observed in our systematic review differ from
reported antibiotic prescriptions from literature, or websites
(12, 73). However, these numbers are based on national or
local registries and include in-hospital patients, not reflecting
our interest on use of antibiotics in ED settings. Next, not all
countries are represented in our systematic review and only
Switzerland, USA are represented by more than one study. For
the latter two, however we observed high variability in antibiotic
prescription within studies of the same country. Even within
studies focusing on similar group of diagnoses, we observed
a large heterogeneity in their way of patient selection and
their type of febrile illness. Therefore, we think these antibiotic
prescriptions cannot be considered to be representative for the
general population of febrile children in a country.
Limited evidence was found for age effects on antibiotic
prescriptions, potentially due to age distribution among study
populations. Infants below 2 months are underrepresented in
our review. From community studies, we know that pre-school
children are more frequently exposed to antibiotic therapy
(13).
After exclusion of two outlier studies given their patient
selection and outcome definition (42, 50), we observed in
studies on children with fever a trend toward higher antibiotic
prescriptions in studies with higher SBI rates is noticeable.
This, however, only explains some variation in antibiotic
prescription.
Similar to studies in primary care, watchful waiting
intervention seems highly effective for reducing antibiotic
use in AOM at the ED (74). Results however are limited to
patients above the age of 6 months that did not appear toxic
and it is questionable if the study populations were large
enough to detect serious adverse outcomes such as meningitis.
Although the most frequently studied intervention, rapid viral
testing for influenza has no additional effect above testing
on indication and controversial evidence was found for its
effect. Effects of guidelines are seen in two well-defined groups
(respiratory infections or young febrile infants) and including
a well-defined implementation plan. Implementation of a
clinical decision model to reduce antibiotic prescriptions was
only tested in a tertiary pediatric university ED and antibiotic
reduction was not a primary outcome of this study (17). All other
interventions are not (yet) proven to be effective for reducing
the antibiotic prescriptions in children on the ED. Overall the
evidence to reduce antibiotic prescription in the emergency
department remains limited. We observed a general association
between antibiotic prescription and the type of prescriber, i.e.,
pediatricians prescribe less antibiotics than general physicians
may suggest that guideline implementation could be most
effective in hospitals with general physicians treating children in
the ED.
Limitations
The quality of the studies that reported about fever in general
was low to moderate, with only one high quality study (3).
Specific drawbacks of study design are included in the MINOR
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TABLE 4 | Influence of intervention on antibiotic prescription.
Reference, Country Median (IQR) or
Mean age ± SD U
Intervention Inclusion N intervention
total, % AB
N controls total,
% AB
FEVER IN GENERAL
Aronson et al. (21), US 46 days (37–53) CPG recommending ceftriaxone
compared to no CPG
Fever 306, 64.1%ˆ 1.304, 11.7%ˆ
45 days (37–53)
CPG recommending against
ceftriaxone compared to no CPG
313, 10.9%ˆ 1.304, 11.7%ˆ
Jain et al. (41), US NR Physician feedback through
scorecards
Fever 8.961, 10.8% 1.0114, 12%
Lacroix et al. (46), France 3.4 months
(1.5–10.4)
Lab Score FWS 131, 41.2% 140, 42.1%
4.8 months
(1.7–10.4)
Manzano et al. (49), Canada 12 ± 8 months◦ PCT testing Fever 192, 25% 192, 28%
12 ± 8 months◦
Murray et al. (53), US 36 days ± 13.8 Implementation of a clinical
pathway
Fever 296, 69% 224, 72%
de Vos-Kerkhof et al. (68),
Netherlands
1.7 years (0.8–3.9) Clinical decision model Fever 219, 35.6% 220, 41.8%
2.0 years (1.0–4.2)
(SUSPICION OF) BACTERIAL INFECTIONS
Nelson et al. (54), US * 2.8 years (4.4) Antibiotic prescription rate before
and after CXR result
Pneumonia 1610, 23% 1610, 7%
de Vos-Kerkhof et al. (68),
Netherlands
1.8 (0.9–4.1) Clinical decision model Fever and SBI 192, 22.9% 192, 27.1%
Waddle and Jhaveri (69), US 17 months ± 11◦ PCV7 FWS and BC 275, 57.2% 148, 60.8%
15 months ± 10◦
INFLUENZA
Blaschke 2014 (25), US⋄ 53% < 18 years Rapid viral testing
(positive/negative RVT)
RVT performed NR, 11% NR, 47%
Benito-Fernández et al. (24),
Spain
6.86 months ± 6.3◦ Rapid viral testing
(positive/negative RVT)
Fever without source 84, 0% 122, 38.5%
6.55 months ± 6.8◦
Bonner et al. (27), US NR Rapid viral testing (RVT /no RVT) Influenza positive 96, 7% 106, 25%
Doan et al. (33), Canada 15 months (3–36) Rapid viral testing
(POCT/standard testing)
Acute respiratory
symptoms
89, 18% 110, 21%
14 months (4–34)
Iyer et al. (40), US ±75% 6–24 months Rapid viral testing (RVT/ no RVT) Fever 345, 25.3% 355, 30.5%
Li-Kim-Moy et al. (48),
Australia
3.1 years (1.1–7.4) Rapid viral testing
(POCT/standard testing)
Lab proven influenza 236, 33% 65, 54%
Özkaya et al. (58), Turkey 5.7 years ± 3.4◦ Rapid viral testing (RVT /no RVT) Influenza-like illness 50, 58% 47, 100%
4.25 years ± 2.02◦
Poehling et al. (62), US NR Rapid viral testing (RVT/no RVT) Fever or ARS during
influenza season
135, 32% 170, 29%
Sharma et al. (64), US 9 months◦ Rapid viral testing (RVT /no RVT) Fever and positive
influenza test
47, 2% 25, 24%
AOM
Chao et al. (29), US 5.01 years
(3.67–6.68)
Delayed prescription with and
without prescription
AOM 100, 19% 106, 46%
3.73 years
(2.82–5.75)
Fischer et al. (34), US 68% 2–6 years Wait-and-see prescription in
AOM
AOM 144, 27% N.A.
(Continued)
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TABLE 4 | Continued
Reference, Country Median (IQR) or
Mean age ± SD U
Intervention Inclusion N intervention
total, % AB
N controls total,
% AB
McCormick et al. (52), US ±60% < 1 years Wait-and-see prescription in
AOM
AOM 100, 34% 109, 100%
Nibhanipudi et al. (55), US* 5.72 years ± 0.38◦
(m)
WBC >15.000 or WBC <15.000 AOM 93, 3% 7, 100%
7.41 years ± 0.75◦
(f)
Spiro et al. (66), US 3.2 years Wait-and-see prescription in
AOM
AOM 138, 38% 145, 87%
3.6 years
RTI Other
Angoulvant et al. (20),
France
17 months (7–40) Implementing guidelines ARTI NR, 21% NR, 32.1%
Ayanruoh et al. (22), US NR Rapid streptococcal testing Clinical diagnosis of
pharyngitis
6.557, 22.45% 1.723, 41.38%
Linder et al. (47), US 45% 6–11 years GABHS testing in sore throat Sore throat NR, 48% NR, 51%
Ouldali et al. (59), France 1.6 years (0.7–3.6) Implementation of national
guidelines
ARTI 134.450,−28.4% 61.612
1.7 years (0.7–3.7)
Spiro et al. (65), US 17.3 months◦ Tympanometry for reduction
antibiotics in AOM
Fever or ARS 341, 28.8% 340, 26.8%
17.2 months◦
Wheeler et al. (70), US 3 years (1
months−20 years)
Videotape in waiting room Viral infections 71, 4.2% 73, 6.8%
∧Only parenteral antibiotic prescription rate is given. Highlighted studies indicate studies with significant results.
*Estimated/calculated from numbers in article.
◦Mean age given, median age not reported.
assessment as a measure of quality. The use of MINORS
in combination with the study population and study aim
helps to increase the reproducibility of this review and made
it possible to compare the different levels of evidence (16).
Most studies did not reported on missing values regarding
antibiotic prescription, which could lead to an underestimation
of antibiotic prescriptions. In a substantial part of the included
papers, antibiotic prescription was not the primary outcome.
This may explain some diversity in antibiotic prescriptions,
although this was partially corrected for in the quality
assessment.
This systematic review focuses on prescription of antibiotics
in the ED setting. In many European countries, antibiotics are
available as over the counter drugs as well (75). This issue is not
accounted for by any of the articles, which may lead to a general
underestimation of the antibiotic use.
Unfortunately, we observed a large heterogeneity of the
studies or had only 1 study per diagnosis group, hampering
meta-analysis. Most heterogeneity is caused by specific patient
selection (age, setting), by study design (intervention vs.
observational cohort study). This also applies to the population
of febrile children<36 months that constitute the majority of ED
attendances.
Future Research Recommendations
To validly estimate baseline antibiotic prescriptions in children
with fever presenting to the emergency department we need
observational studies including the general spectrum of febrile
children. Being able to determine influences of antibiotic
prescription, we should address geographical and cultural
influences, differences in setting, adherence area, general patient
characteristics, and descriptors of illness severity. Insight in
these determinants may help to define targets for intervention
to reduce antibiotic prescriptions. Next, this information will
contribute to valid power calculations for intervention studies
and to generalize effects to other settings.
CONCLUSION
A summary of studies on antibiotic prescription in the 5
main diagnostic groups at the ED did not yield uniform
outcomes. There seems to be a trend toward higher antibiotic
prescriptions in younger children and for diagnoses that are
more often related to bacterial infections. Delayed antibiotic
prescription in children with acute otitis media and guidelines
for fever/LRTI seem useful to reduce antibiotic prescriptions at
the ED. However no strict conclusions can be drawn on the
basis of this review because of the large heterogeneity of type of
studies and included populations. This means that there is still
a gap in knowledge on the determining factors that influence
antibiotic prescription in febrile children presenting to the ED.
A multicentre study including a wide range of countries on a
general population of febrile children would be recommended
to provide a valid baseline of antibiotic prescriptions in
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general, and influencing factors that identify targets for future
interventions.
AUTHOR CONTRIBUTIONS
EvdV was responsible for search, dataextraction and writing
of the manuscript. HM, SM, and AG contributed to
datainterpretation and writing of the manuscript. RO concepted
the idea of the paper, supervised search, dataextraction, and
writing of the manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fped.
2018.00260/full#supplementary-material
REFERENCES
1. Fields E, Chard J, Murphy MS, Richardson M, Guideline Development G,
Technical T. Assessment and initial management of feverish illness in children
younger than 5 years: summary of updated NICE guidance. BMJ (2013)
346:f2866. doi: 10.1136/bmj.f2866
2. Nijman RG, Vergouwe Y, Thompson M, van Veen M, van Meurs AH, van
der Lei J, et al. Clinical prediction model to aid emergency doctors managing
febrile children at risk of serious bacterial infections: diagnostic study. BMJ
(2013) 346:f1706. doi: 10.1136/bmj.f1706
3. Craig JC, Williams GJ, Jones M, Codarini M, Macaskill P, Hayen A, et al. The
accuracy of clinical symptoms and signs for the diagnosis of serious bacterial
infection in young febrile children: Prospective cohort study of 15 781 febrile
illnesses. BMJ (2010) 340:1015. doi: 10.1136/bmj.c1594
4. Brett A, Bielicki J, Newland JG, Rodrigues F, Schaad UB, Sharland M.
Neonatal and pediatric antimicrobial stewardship programs in europe -
defining the research agenda. Pediatr Infect Dis J. (2013) 32:e456–65.
doi: 10.1097/INF.0b013e31829f0460
5. Otters HB, van der Wouden JC, Schellevis FG, van Suijlekom-Smit
LW, Koes BW. Trends in prescribing antibiotics for children in Dutch
general practice. J Antimicrob Chemother. (2004) 53:361–6. doi: 10.1093/jac/
dkh062
6. Blair PS, Turnbull S, Ingram J, Redmond N, Lucas PJ, Cabral C,
et al. Feasibility cluster randomised controlled trial of a within-
consultation intervention to reduce antibiotic prescribing for children
presenting to primary care with acute respiratory tract infection and
cough. BMJ Open. (2017) 7:e014506. doi: 10.1136/bmjopen-2016-
014506
7. Stille CJ, Rifas-Shiman SL, Kleinman K, Kotch JB, Finkelstein JA. Physician
responses to a community-level trial promoting judicious antibiotic use. Ann
FamMed. (2008) 6:206–12. doi: 10.1370/afm.839
8. Meeker D, Linder JA, Fox CR, Friedberg MW, Persell SD, Goldstein NJ, et
al. Effect of behavioral interventions on inappropriate antibiotic prescribing
among primary care practices: a randomized clinical trial. JAMA (2016)
315:562–70. doi: 10.1001/jama.2016.0275
9. Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A,
et al. Interventions to improve antibiotic prescribing practices for
hospital inpatients. Cochrane Database Syst Rev. (2013) 2:CD003543.
doi: 10.1002/14651858.CD003543.pub4
10. Lieberman JM. Appropriate antibiotic use and why it is important: the
challenges of bacterial resistance. Pediatr Infect Dis J. (2003) 22:1143–51.
doi: 10.1097/01.inf.0000101851.57263.63
11. Versporten A, Sharland M, Bielicki J, Drapier N, Vankerckhoven V, Goossens
H, et al. The antibiotic resistance and prescribing in European Children
project: a neonatal and pediatric antimicrobial web-based point prevalence
survey in 73 hospitals worldwide. Pediatr Infect Dis J. (2013) 32:e242–53.
doi: 10.1097/INF.0b013e318286c612
12. Molstad S, Lundborg CS, Karlsson AK, Cars O. Antibiotic prescription rates
vary markedly between 13 European countries. Scand J Infect Dis. (2002)
34:366–71. doi: 10.1080/00365540110080034
13. Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and
prevalence rate in the outpatient paediatric population: analysis of surveys
published during 2000–2005. Eur J Clin Pharmacol. (2007) 63:1099–106.
doi: 10.1007/s00228-007-0376-3
14. Ryan J, Greene SK, Kleinma KP, Lakoma MD. Trends in antibiotic
use in massachusetts children, 2000-2009. J Emerg Med. (2012) 43:e381.
doi: 10.1016/j.jemermed.2012.09.009
15. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin
SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of
national pharmaceutical sales data. Lancet Infect Dis. (2014) 14:742–50.
doi: 10.1016/S1473-3099(14)70780-7
16. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J.
Methodological index for non-randomized studies (minors): development
and validation of a new instrument. ANZ J Surg. (2003) 73:712–6.
doi: 10.1046/j.1445-2197.2003.02748.x
17. de Vos-Kerkhof E, Geurts DH, Wiggers M, Moll HA, Oostenbrink
R. Tools for ’safety netting’ in common paediatric illnesses: a
systematic review in emergency care. Arch Dis Child. (2016) 101:131–9.
doi: 10.1136/archdischild-2014-306953
18. van Tulder M, Furlan A, Bombardier C, Bouter L, Editorial Board of the
Cochrane Collaboration Back Review G. Updated method guidelines for
systematic reviews in the cochrane collaboration back review group. Spine
(2003) 28:1290–9. doi: 10.1097/01.BRS.0000065484.95996.AF
19. Ahmed MN, Muyot MM, Begum S, Smith P. Antibiotic prescription
pattern for viral respiratory illness in emergency room and ambulatory
care settings. Clin Pediatr. (2010). 49:452–7. doi: 10.1177/00099228093
57786
20. Angoulvant F, Skurnik D, Bellanger H, Abdoul H. Impact of implementing
French antibiotic guidelines for acute respiratory-tract infections in a
paediatric emergency department, 2005–2009. Eur J Ofin Microbiol Infect Dis.
(2011) 31:1295–303. doi: 10.1007/s10096-011-1442-4
21. Aronson PL, Thurm C, Williams DJ, Nigrovic LE, Alpern ER, Tieder JS,
et al. Association of clinical practice guidelines with emergency department
management of febrile infants≤56 days of age. J Hosp Med. (2015) 10:358–65.
doi: 10.1002/jhm.2329
22. Ayanruoh S, Waseem M, Quee F. Impact of rapid streptococcal test on
antibiotic use in a pediatric emergency department. Ped Emerg Care (2009)
25:748–50. doi: 10.1097/PEC.0b013e3181bec88c
23. Benin AL, Vitkauskas G, Thornquist E, Shiffman RN, Concato J,
Krumholz HM, et al. Improving diagnostic testing and reducing overuse
of antibiotics for children with pharyngitis: a useful role for the
electronic medical record. Pediatric Infect Dis J. (2003) 22:1043–7.
doi: 10.1097/01.inf.0000100577.76542.af
24. Benito-Fernandez J, Vazquez-Ronco MA, Morteruel-Aizkuren E, Mintegui-
Raso S, Sanchez-Etxaniz J, Fernandez-Landaluce A. Impact of rapid viral
testing for influenza A and B viruses on management of febrile infants
without signs of focal infection. Pediatr Infect Dis J. (2006) 25:1153–7.
doi: 10.1097/01.inf.0000246826.93142.b0
25. Blaschke AJ, Shapiro DJ, Pavia AT, Byington CL, Ampofo K, Stockmann C,
et al. A national study of the impact of rapid influenza testing on clinical
care in the emergency department. J Pediatric Infect Dis Soc. (2014) 3:112–8.
doi: 10.1093/jpids/pit071
26. BraunerM, GoldmanM, Kozer E. Extreme leucocytosis and the risk of serious
bacterial infections in febrile children. Arch Dis Childhood. (2010) 95:209–12.
doi: 10.1136/adc.2009.170969
27. Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact
of the rapid diagnosis of influenza on physician decision-making and
patient management in the pediatric emergency department: results of
Frontiers in Pediatrics | www.frontiersin.org 12 October 2018 | Volume 6 | Article 260
van de Voort et al. Antibiotic Use in Febrile Children in the ED
a randomized, prospective, controlled trial. Pediatrics (2003) 112:363–7.
doi: 10.1542/peds.112.2.363
28. Bustinduy AL, Chis Ster I, Shaw R, Irwin A, Thiagarajan J, Beynon
R, et al. Predictors of fever-related admissions to a paediatric
assessment unit, ward and reattendances in a South London emergency
department: the CABIN 2 study. Arch Dis Child. (2017) 102:22–8.
doi: 10.1136/archdischild-2016-310494
29. Chao JH, Kunkov S, Reyes LB, Lichten S, Crain EF. Comparison of
two approaches to observation therapy for acute otitis media in the
emergency department. Pediatrics (2008) 121:1352–6. doi: 10.1542/peds.2007-
2278
30. Coco AS, Horst MA, Gambler AS. Trends in broad-spectrum antibiotic
prescribing for children with acute otitis media in the United States, 1998-
2004. BMC Pediatr. (2009) 9:41. doi: 10.1186/1471-2431-9-41
31. Colvin JM, Muenzer JT, Jaffe DM, Smason A, Deych E, Shannon WD, et al.
Detection of viruses in young children with fever without an apparent source.
Pediatrics (2012) 130:e1455–e62. doi: 10.1542/peds.2012-1391
32. Copp HL, Shapiro DJ, Hersh AL. National ambulatory antibiotic prescribing
patterns for pediatric urinary tract infection, 1998-2007. Pediatrics (2011)
127:1027–33. doi: 10.1542/peds.2010-3465
33. Doan QH, Kissoon N, Dobson S, Whitehouse S, Cochrane D, Schmidt
B, et al. A randomized, controlled trial of the impact of early and
rapid diagnosis of viral infections in children brought to an emergency
department with febrile respiratory tract illnesses. J Pediatr. (2009) 154:91–5.
doi: 10.1016/j.jpeds.2008.07.043
34. Fischer T, Singer AJ, Chale S. Observation option for acute otitis media
in the emergency department. Pediatr Emerg Care (2009) 25:575–8.
doi: 10.1097/PEC.0b013e3181b91ff0
35. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and
C-reactive protein tests in children with fever without localizing signs
of infection seen in a referral center. Pediatrics (2003) 112:1054–60
doi: 10.1542/peds.112.5.1054
36. Goldman RD, Scolnik D, Chauvin-Kimoff L, Farion KJ, Ali S,
Lynch T, et al. Practice variations in the treatment of febrile infants
among pediatric emergency physicians. Pediatrics (2009) 124:439–45.
doi: 10.1542/peds.2007-3736
37. van Houten CB, de Groot JAH, Klein A, Srugo I, Chistyakov I, de Waal
W, et al. A host-protein based assay to differentiate between bacterial
and viral infections in preschool children (OPPORTUNITY): a double-
blind, multicentre, validation study. Lancet Infect Dis. (2017) 17:431–40.
doi: 10.1016/S1473-3099(16)30519-9
38. Irwin AD, Grant A, Williams R, Kolamunnage-Dona R, Drew RJ,
Paulus S, et al. Predicting risk of serious bacterial infections in febrile
children in the emergency department. Pediatrics (2017) 140:e20162853.
doi: 10.1542/peds.2016-2853
39. Isaacman DJ, Kaminer K, Veligeti H, Jones M, Davis P, Mason JD.
Comparative practice patterns of emergency medicine physicians
and pediatric emergency medicine physicians managing fever in
young children. Pediatrics (2001) 108:354–8. doi: 10.1542/peds.
108.2.354
40. Iyer SB, GerberMA, PomerantzWJ,Mortensen JE, Ruddy RM. Effect of point-
of-care influenza testing onmanagement of febrile children. Acad Emerg Med.
(2006) 13:1259–68. doi: 10.1197/j.aem.2006.07.026
41. Jain S, Frank G, McCormick K, Wu B, Johnson BA. Impact of physician
scorecards on emergency department resource use, quality, and efficiency.
Pediatrics (2015) 136:e670–e9. doi: 10.1542/peds.2014-2363
42. Khine H, Goldman DL, Avner JR. Management of fever in postpneumococcal
vaccine era: comparison of management practices by pediatric emergency
medicine and general emergency medicine physicians. Emerg Med Int. (2014)
2014:702053. doi: 10.1155/2014/702053
43. Kilic A, Unuvar E, Sutcu M, Suleyman A, Tamay Z, Yildiz I, et al.
Acute obstructive respiratory tract diseases in a pediatric emergency
unit: Evidence-based evaluation. Pediatr Emerg Care (2012) 28:1321–7.
doi: 10.1097/PEC.0b013e3182768d17
44. Kornblith AE, Fahimi J, Kanzaria HK, Wang RC. Predictors
for under-prescribing antibiotics in children with respiratory
infections requiring antibiotics. Am J Emerg Med. (2018) 36:218–25.
doi: 10.1016/j.ajem.2017.07.081
45. Kronman MP, Hersh AL, Feng R, Huang YS. Ambulatory visit rates and
antibiotic prescribing for children with pneumonia, 1994–2007. Pediatrics
(2011) 127:411–18. doi: 10.1542/peds.2010-2008
46. Lacroix L, Manzano S, Vandertuin L, Hugon F, Galetto-Lacour A, Gervaix A.
Impact of the lab-score on antibiotic prescription rate in children with fever
without source: a randomized controlled trial. PLoS ONE (2014) 9:e0115061.
doi: 10.1371/journal.pone.0115061
47. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children
with sore throat. JAMA (2005) 294:2315–22. doi: 10.1001/jama.294.18.2315
48. Li-Kim-Moy J, Dastouri F, Rashid H, Khandaker G, Kesson A, McCaskill
M, et al. Utility of early influenza diagnosis through point-of-care testing
in children presenting to an emergency department. J Paediatr Child Health
(2016) 52:422–9. doi: 10.1111/jpc.13092
49. Manzano S, Bailey B, Girodias JB, Galetto-Lacour A, Cousineau J, Delvin E.
Impact of procalcitonin on the management of children aged 1 to 36 months
presenting with fever without source: a randomized controlled trial. Am J
Emerg Med. (2010) 28: 647–53. doi: 10.1016/j.ajem.2009.02.022
50. Massin MM, Montesanti J, Lepage P. Management of fever without source in
young children presenting to an emergency room.Acta Paediatr Int J Paediatr.
(2006) 95:1446–50. doi: 10.1080/08035250600669751
51. McCaig LF, McDonald LC, Cohen AL, Kuehnert MJ. Increasing blood culture
use at US Hospital Emergency Department visits, 2001 to 2004. Ann Emerg
Med. (2007) 50:42–48.e2 doi: 10.1016/j.annemergmed.2006.12.002
52. McCormick DP, Chonmaitree T, Pittman C, Saeed K. Nonsevere acute
otitis media: a clinical trial comparing outcomes of watchful waiting versus
immediate antibiotic treatment. Am Acad Pediatrics (2005) 115:1455–65.
doi: 10.1542/peds.2004-1665
53. Murray AL, Alpern E, Lavelle J, Mollen C. Clinical pathway effectiveness:
febrile young infant clinical pathway in a pediatric emergency department.
Pediatr Emerg Care (2017) 33:e33–e7. doi: 10.1097/PEC.0000000000000960
54. Nelson KA, Morrow C, Wingerter SL, Bachur RG, Neuman MI.
Impact of chest radiography on antibiotic treatment for children
with suspected pneumonia. Pediatr Emerg Care (2016) 32:514–9.
doi: 10.1097/PEC.0000000000000868
55. Nibhanipudi KV, Hassan GW, Jain A. The utility of peripheral white blood cell
count in cases of acute otitis media in children between 2 years and 17 years
of age. Int J Otorhinolaryngol. (2016) 18. doi: 10.5580/IJORL.38086
56. Ochoa C, Inglada L, Eiros JM, Solis G, Vallano A, Guerra L, et al.
Appropriateness of antibiotic prescriptions in community-acquired acute
pediatric respiratory infections in Spanish emergency rooms. Pediatr Infect
Dis J. (2001) 20:751–8. doi: 10.1097/00006454-200108000-00007
57. Ong S, Nakase J, Moran GJ, Karras DJ. Antibiotic use for emergency
department patients with upper respiratory infections: prescribing practices,
patient expectations, and patient satisfaction. Ann Emerg Med. (2007) 50:213–
20. doi: 10.1016/j.annemergmed.2007.03.026
58. Ozkaya E, Cambaz N, Coskun Y, Mete F, Geyik M, Samanci N. The effect
of rapid diagnostic testing for influenza on the reduction of antibiotic use
in paediatric emergency department. Acta Paediatr Int J Paediatr. (2009)
98:1589–92. doi: 10.1111/j.1651-2227.2009.01384.x
59. Ouldali N, Bellettre X, Milcent K, Guedj R, de Pontual L, Cojocaru B, et
al. Impact of implementing national guidelines on antibiotic prescriptions
for acute respiratory tract infections in pediatric emergency departments:
an interrupted time series analysis. Clin Infect Dis. (2017) 65:1469–76.
doi: 10.1093/cid/cix590
60. Planas AM, Almagro CM, Cubells CL, Julian AN, Selva L, Fernandez JP,
et al. Low prevalence of invasive bacterial infection in febrile infants under
3 months of age with enterovirus infection. Clin Microbiol Infect. (2012)
18:856–61. doi: 10.1111/j.1469-0691.2011.03671.x
61. Ploin D, Gillet Y, Morfin F, Fouilhoux A, Billaud G, Liberas S,
et al. Influenza burden in febrile infants and young children in a
pediatric emergency department. Pediatr Infect Dis J. (2007) 26:142–7.
doi: 10.1097/01.inf.0000253062.41648.60
62. Poehling KA, Zhu Y, Tang YW, Edwards K. Accuracy and impact of a point-
of-care rapid influenza test in young children with respiratory illnesses. Arch
Pediatr Adolesc Med. (2006) 160:713–8. doi: 10.1001/archpedi.160.7.713
63. Shah S, Bourgeois F, Mannix R, Nelson K, Bachur R, Neuman MI. Emergency
department management of febrile respiratory illness in children. Pediatr
Emerg Care (2016) 32:429–34. doi: 10.1097/PEC.0000000000000721
Frontiers in Pediatrics | www.frontiersin.org 13 October 2018 | Volume 6 | Article 260
van de Voort et al. Antibiotic Use in Febrile Children in the ED
64. Sharma V, Denise Dowd M, Slaughter AJ, Simon SD. Effect of rapid diagnosis
of influenza virus type A on the emergency department management of
febrile infants and toddlers. Arch Pediatr Adolesc Med. (2002) 156:41–3.
doi: 10.1001/archpedi.156.1.41
65. Spiro DM, King WD, Arnold DH, Johnston C, Baldwin S. A randomized
clinical trial to assess the effects of tympanometry on the diagnosis
and treatment of acute otitis media. Pediatrics (2004) 114:177–81.
doi: 10.1542/peds.114.1.177
66. Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED.
Wait-and-see prescription for the treatment of acute otitis media: a
randomized controlled trial. J Am Med Assoc. (2006) 296:1235–41.
doi: 10.1001/jama.296.10.1235
67. Trautner BW, Caviness AC, Gerlacher GR. Prospective evaluation of the
risk of serious bacterial infection in children who present to the emergency
department with hyperpyrexia (temperature of 106 F or higher). Pediatrics
(2006) 118:34–40. doi: 10.1542/peds.2005-2823
68. de Vos-Kerkhof E, Nijman RG, Vergouwe Y, Polinder S, Steyerberg
EW, van der Lei J, et al. Impact of a clinical decision model for
febrile children at risk for serious bacterial infections at the emergency
department: a randomized controlled trial. PLoS ONE (2015) 10:e0127620.
doi: 10.1371/journal.pone.0127620
69. Waddle E, Jhaveri R. Outcomes of febrile children without localising signs
after pneumococcal conjugate vaccine. Arch Dis Child. (2008) 94:144–7.
doi: 10.1136/adc.2007.130583
70. Wheeler JG, Fair M, Simpson PM, Rowlands LA. Impact of a
waiting room videotape message on parent attitudes toward pediatric
antibiotic use. Pediatrics (2001) 108:591–6. doi: 10.1542/peds.
108.3.591
71. Lacour AG, Zamora SA, Vadas L, Lombard PR, Dayer JM, et al. Procalcitonin,
IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of
serious bacterial infections in children with fever without localising signs. Eur
J Pediatr. (2001) 160:95–100.
72. Ahmed A, Brito F, Goto C, Hickey SM, Olsen KD, Trujillo M, et al. Clinical
utility of the polymerase chain reaction for diagnosis of enteroviral meningitis
in infancy. J Pediatr. (1997) 131:393–7. doi: 10.1016/S0022-3476(97)80064-9
73. The Center for Disease DynamicsEconomy and Policy. Antibiotic Prescribing
Rates by Country.Available online at: www.cddep.org (Accessed July 20, 2018).
74. Tyrstrup M, Beckman A, Molstad S, Engstrom S, Lannering C, Melander E,
et al. Reduction in antibiotic prescribing for respiratory tract infections in
Swedish primary care-a retrospective study of electronic patient records. BMC
Infect Dis. (2016) 16:709. doi: 10.1186/s12879-016-2018-9
75. Both L, Botgros R, Cavaleri M. Analysis of licensed over-the-counter (OTC)
antibiotics in the European Union and Norway, 2012. Euro Surveill. (2015)
20:30002. doi: 10.2807/1560.7917.ES.2015.20.34.30002
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 van de Voort, Mintegi, Gervaix, Moll and Oostenbrink. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Pediatrics | www.frontiersin.org 14 October 2018 | Volume 6 | Article 260
